196 related articles for article (PubMed ID: 25317250)
1. Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment.
Arevalo JF; Serrano MA; Arias JD
World J Diabetes; 2014 Oct; 5(5):724-9. PubMed ID: 25317250
[TBL] [Abstract][Full Text] [Related]
2. En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy.
Arevalo JF
Ophthalmology; 2008 Jun; 115(6):e21-5. PubMed ID: 18423870
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
[TBL] [Abstract][Full Text] [Related]
4. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
Arevalo JF; Maia M; Flynn HW; Saravia M; Avery RL; Wu L; Eid Farah M; Pieramici DJ; Berrocal MH; Sanchez JG
Br J Ophthalmol; 2008 Feb; 92(2):213-6. PubMed ID: 17965108
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
Yang CS; Hung KC; Huang YM; Hsu WM
J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
[TBL] [Abstract][Full Text] [Related]
6. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
[TBL] [Abstract][Full Text] [Related]
7. Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales' Disease.
Ersöz MG; Hocaoğlu M; Sayman Muslubaş IB; Arf S; Karaçorlu M
Turk J Ophthalmol; 2021 Apr; 51(2):102-106. PubMed ID: 33951898
[TBL] [Abstract][Full Text] [Related]
8. A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.
Ho J; Grabowska A; Ugarte M; Muqit MM
Eye (Lond); 2018 Sep; 32(9):1449-1454. PubMed ID: 29786087
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy.
Alshaikhsalama AM; Thompson KN; Patrick H; Lee J; Voor TA; Wang AL
Ophthalmol Retina; 2024 Mar; ():. PubMed ID: 38447921
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up.
Arevalo JF; Lasave AF; Wu L; Maia M; Diaz-Llopis M; Alezzandrini AA; Brito M;
Retina; 2017 Feb; 37(2):334-343. PubMed ID: 27429384
[TBL] [Abstract][Full Text] [Related]
11. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
[TBL] [Abstract][Full Text] [Related]
12. Twenty-seven-gauge vitrectomy for combined tractional and rhegmatogenous retinal detachment involving the macula associated with proliferative diabetic retinopathy.
Cruz-Iñigo YJ; Berrocal MH
Int J Retina Vitreous; 2017; 3():38. PubMed ID: 29043092
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial.
Arevalo JF; Lasave AF; Kozak I; Al Rashaed S; Al Kahtani E; Maia M; Farah ME; Cutolo C; Brito M; Osorio C; Navarro P; Wu L; Berrocal MH; Morales-Canton V; Serrano MA; Graue-Wiechers F; Sabrosa NA; Alezzandrini AA; Gallego-Pinazo R;
Am J Ophthalmol; 2019 Nov; 207():279-287. PubMed ID: 31095954
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up.
Arevalo JF; Wu L; Sanchez JG; Maia M; Saravia MJ; Fernandez CF; Evans T
Eye (Lond); 2009 Jan; 23(1):117-23. PubMed ID: 17891058
[TBL] [Abstract][Full Text] [Related]
15. The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy.
Qamar RM; Saleem MI; Saleem MF
Int J Ophthalmol; 2013; 6(5):671-4. PubMed ID: 24195047
[TBL] [Abstract][Full Text] [Related]
16. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
Hu X; Pan Q; Zheng J; Song Z; Zhang Z
BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal detachment secondary to proliferative diabetic retinopathy.
Chen PL; Chen YT; Chen SN
PLoS One; 2021; 16(3):e0249139. PubMed ID: 33765074
[TBL] [Abstract][Full Text] [Related]
18. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
[TBL] [Abstract][Full Text] [Related]
19. [Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy].
Zheng CZ; Ren XJ; Ke YF; Wen DJ; Li XR
Zhonghua Yan Ke Za Zhi; 2021 Jun; 57(6):440-446. PubMed ID: 34098693
[No Abstract] [Full Text] [Related]
20. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
